Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
65 hedge funds and large institutions have $258M invested in Icosavax, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 18 closing their positions.
154% more capital invested
Capital invested by funds: $101M → $258M (+$157M)
40% more call options, than puts
Call options by funds: $837K | Put options by funds: $598K
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
11% less funds holding
Funds holding: 73 → 65 (-8)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.72M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$4.93M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.01M |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.57M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$318K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$3.93M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.01M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$738K |
| 4 |
BlackRock
New York
|
-$625K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$529K |
ICVX Hedge Fund Activity: Q4 2022 in Review
65 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q4 2022, worth a combined $258M — up 154% from $101M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ICVX and 11 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 25 added.
The largest buyer was Fidelity Investments, adding an estimated $6.72M. The largest seller was Adams Street Partners, cutting an estimated $3.93M.
- 65 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q4 2022, down from 73 in Q3 2022.
- Funds reported $258M of Icosavax, Inc. Common Stock stock for Q4 2022, up 154% quarter-over-quarter.
- 11 funds opened new Icosavax, Inc. Common Stock positions in Q4 2022 and 18 closed out, a net change of -7 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q4 2022 was Fidelity Investments, an estimated $6.72M added.
- The largest Icosavax, Inc. Common Stock seller in Q4 2022 was Adams Street Partners, an estimated $3.93M sold.
Based on aggregated 13F filings for Q4 2022.